XT
GRTS

XTX Topco’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

XTX Topco’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-77,545
Closed -$45K – 3109
2024
Q3 		$45K Buy
77,545
+67,347
+660% +$37.7K ﹤0.01% 1710
2024
Q2 		$6.3K Buy
+10,198
New +$8.62K ﹤0.01% 1735
2024
Q1 		– Sell
-12,775
Closed -$26.1K – 2440
2023
Q4 		$26.1K Buy
12,775
+132
+1% +$241 0.01% 1331
2023
Q3 		$21.7K Sell
12,643
-53,498
-81% -$95K ﹤0.01% 1367
2023
Q2 		$129K Buy
+66,141
New +$155K 0.02% 1122
2022
Q4 		– Sell
-50,517
Closed -$130K – 1583
2022
Q3 		$130K Buy
50,517
+16,151
+47% +$51.4K 0.03% 894
2022
Q2 		$83K Sell
34,366
-8,994
-21% -$23.6K 0.03% 688
2022
Q1 		$179K Buy
+43,360
New +$230K 0.08% 432

Other funds holding GRTS

BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

XTX Topco's GRTS Position: Q4 2024 in Review

XTX Topco sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 77,545 shares — an estimated $45K sold.

XTX Topco first reported a position in GRTS in Q1 2022 and held it in 8 quarters. The position peaked at $179K in Q1 2022. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • XTX Topco reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • XTX Topco sold 77,545 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $45K.
  • XTX Topco first reported a position in Gritstone bio, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • XTX Topco's Gritstone bio, Inc. Common Stock position peaked at $179K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on XTX Topco's 13F filing for Q4 2024, filed 13 Feb 2025.